Prolactin and systemic lupus erythematosus: prolactin secretion by SLE lymphocytes and proliferative (autocrine) activity

Abstract

Accumulated evidence suggests that prolactin (PRL) is an important immunoregulator and might have a role in the pathogenesis of systemic lupus erythematosus (SLE). Moreover, a PRL-like molecule is secreted by normal human lymphocytes and acts as an autocrine growth factor for lymphoproliferation. The objective of this study was to explore the PRL-like peptide production by peripheral blood mononuclear cells (PBMC) from patients with SLE.

We investigated the PRL secretion by PBMC from six female SLE patients and nine normal subjects (5 women and 4 men). Ficoll-Hypaque isolated PBMC (1 X 106 cells/ml) were cultured with and without maximal stimulatory doses of PHA (1 mg/ml) or PWM (1/200). At 72 h of culture supernatants were harvested and used to determine PRL immunoreactivity by a radioimmunoassay (NIDDK-reagents). Cell extracts and concentrated supernatants were prepared to determine PRL by Western blot analysis (NIDDK-reagents).

SLE non-stimulated PBMC secreted significantly higher levels of PRL than normal non- stimulated PBMC (8.09 ± 4.15 ng/ml vs. 3.48 ± 2.36 ng/ml, P = 0.02 by Mann-Whitney test). High levels of PRL were secreted by SLE-PHA stimulated PBMC (6.88 ± 4.53 ng/ml) and SLE-PWM stimulated PBMC (16.57 ± 16.39 ng/ml) compared with normal-PHA stimulated PBMC (5.83 ± 5.27ng/ml) and normal-PWM stimulated PBMC (8.54 ± 5.49ng/ml), respectively, but the differences were not significant. The maximal production of PRL was found in PWM-stimulated lymphocytes in both groups. Cells extracts prepared from SLE non-stimulated and stimulated PBMC contained a 11 KDa PRL immunoreactive material. Concentrated supernatants from SLE non-stimulated and stimulated PBMC contained both a 11 KDa and a 24-27 KDa PRL immunoreactive material.

Our data indicate that PBMC from patients with SLE have an increased production of PRL-like immunoreactive material. This PRL is released in vitro as two different molecular weight forms, and appears to be derived from B rather than T lymphocytes.

Keywords

immunoregulation neuropeptides autoimmunity

Get full access to this article

View all access options for this article.

References

Jara LJ et al. Prolactin, immunoregulation and autoimmune diseases. Semin Arthritis Rheum 1991; 20: 273-284.

Jara LJ , Lavalle C. , Espinoza LR

Does prolactin have a role in the pathogenesis of systemic lupus erythematosus?

J Rheumatol 1992; 19: 1333-1336 (editorial).

Lavalle C. et al. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J. Rheumatol 1987; 14: 268-272.

Jara-Quezada LJ , Graef A. , Lavalle C. Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus. J Rheumatol 1991; 18: 349-353.

Jara LJ et al. Hyperprolactinemia in systemic lupus erythematosus: association with disease activity. Am J Med Sci 1992; 303: 222-226.

McMurrary R. et al. Prolactin influences autoimmune disease activity in the female B/W mouse. J Immunol 1991; 147: 3790-3787.

Montgomery DW et al. Concanavalin A-stimulated murine splenocytes produce a factor with prolactin-like bioactivity and immunoreactivity. Biochem Res Commun 1987; 145: 692-698.

Mukherjee P. , Mastro AM , Hyme WC Prolactin induction of interleukin-2 receptors on rat splenic lymphocytes. Endocrinology 1990; 126: 88-94.

Yu-Lee L. Prolactin stimulates transcription of growth-related genes in Nb2 T lymphoma cells. Mol Cell Endocrinol 1990 ; 68: 21-28.

10.

Spangelo BL et al. Stimulation of in vivo antibody production and concanavalin A-induced mouse spleen cell mitogenesis by prolactin. Immunopharmacology 1987; 14: 11-20.

11.

Lahat V. et al. Differential effects of prolactin upon activation and differentiation of human B lymphocytes. J Neuroimmunol 1993 ; 47: 35-40.

12.

Russell DH et al. Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine. J Immunol 1985; 134: 3027-3031.

13.

Montgomery DW et al. Identification of prolactin-like proteins synthesized by normal murine lymphocytes. Endocrinology 1990; 127: 2601-2603.

14.

Sabharwal P. et al. Prolactin synthesized and secreted by human peripheral blood mononuclear cells: an autocrine growth factor for lymphoproliferation . Proc Natl Acad Sci USA 1992; 89: 7713-7716.

15.

Montgomery DW et al. Human thymocytes express a prolactin-like messenger ribonucleic acid and synthesize bioactive prolactin-like proteins . Endocrinology 1992; 131: 3019-3026.

16.

Tan EM et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.

17.

Bombardier C. et al and the committee on prognosis studies in SLE. Derivation of the SLEDAI, a disease activity index for lupus patients . Arthritis Rheum 1992; 35: 630-640.

18.

Houghe R. , Delhase M. , Vergani P. Growth hormone and prolactin are paracrine growth and differentiation factors in the haemopoieitic system. Immunol Today 1993; 14: 212-214.

19.

DiMattia GE et al. A human B-lymphoblastoid cell line produces prolactin. Endocrinology 1988; 122: 2508-2517.

20.

Baglia LA , Cruz D. , Shaw JE An Epstein-Barr virus-negative Burkitt lymphoma cell line (sf Ramos) secretes a prolactin-like protein during continuous growth in serum-free medium. Endocrinology 1991; 128: 2266-2272.

21.

Gout PW , Beer CT , Noble RL Prolactin-stimulated growth of cell cultures established from malignant Nb rat lymphomas. Cancer Res 1980; 40: 2433-2436.